Meeting Agenda

Agenda: Science at FDA: Challenges and Opportunities

10:00 a.m. OPENING REMARKS

10:10 a.m. SCIENTIFIC OPPORTUNITIES AND REGULATORY CHALLENGES

• Nanotechnology: Andrew Maynard, Massachusetts Institute of Technology
   
• Information Technology: Sangtae Kim, Purdue University
   
• Devices And Regenerative Medicine: Mike Yaszemski, Mayo Clinic
   
• Genomics: Chris Austin, National Human Genome Research Institute
   
• Food Safety: Mike Taylor, George Washington University
   
• PANEL DISCUSSION
   

12:00 p.m. LUNCH BREAK

12:30 p.m. LUNCHEON SPEAKER: U.S. Representative Rosa DeLauro (D-Connecticut)
            

1:15 p.m. Drug Safety: Robert Califf, Duke University Medical Center
 

1:30 p.m. PANEL: PERSPECTIVES ON FDA’S SCIENCE BASE

• Janet Woodcock, Food and Drug Administration
   
• Chris Bowe, Financial Times
   
• Ellen Sigal, Friends of Cancer Research
   
• Robert Goldstein, Juvenile Diabetes Research Foundation
   
• Robert Young, Fox Chase Cancer Center
   
• Gail Cassell, Eli Lilly and Company
   

3:30 p.m. Meeting Adjourned

Online presentations from "Comparative Effectiveness: State of the Art and Future Direction" are subject to copyright protection. Permission from the speaker is required prior to any copying, reproducing, or rebroadcasting any portion of the speaker's presentations. Additional copyright and legal policies of The National Academies can be read in the National Academies Legal Statement.

Back to Meeting